FDA approves first treatment to delay onset of type 1 diabetes

CNN — A biologic therapy that delays the onset of type 1 diabetes received approval from the U.S. Food and Drug Administration on Thursday. It is the first therapy approved for the prevention of type 1 diabetes. The teplizumab monoclonal antibody, which will be marketed under the Tzield brand, from ProventionBio and Sanofi is administered …

FDA approves first treatment to delay onset of type 1 diabetes Read More »